Flow Cytometry Market to Surge to $10.22B by 2028 with 10.6% CAGR - Driven by Single-Cell Analysis & Immunotherapy

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Flow Cytometry Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $10.22 billion In 2028 At A CAGR Of 10.6%:

The flow cytometry market size has grown strongly in recent years. It will grow from $6.24 billion in 2023 to $6.84 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to immunophenotyping, cancer research, hematology and blood cell analysis, clinical diagnostics, drug discovery and development.

The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $10.22 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to single-cell analysis, immunotherapy and car-t cell development, infectious disease research, biomarker discovery, point-of-care testing (poct). Major trends in the forecast period include multicolor analysis, automation and robotics, imaging flow cytometry, data analysis and informatics, sample preparation innovations.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2509&type=smp

Flow Cytometry Market Major Segments
The flow cytometry market covered in this report is segmented -
1) By Type: Instruments, Reagents & Consumables, Software, Accessories, Services
2) By Technology: Cell-Based, Bead-Based
3) By Application: Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology
4) By End User: Hospitals And Clinics, Academia And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Key Driver - Global Hiv Cases Drive Demand For Flow Cytometry In Diagnosis

The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. Flow cytometry uses light scattering to determine the identity of cells. These cells are given certain markers called CDs (clusters of differentiation), based on the type of scattering. For the HIV virus cell, the clusters of differentiation is called CD4, and based on the number of CD4s in a medium, flow cytometry can be used to diagnose HIV. As the global HIV population continues to grow, the demand for diagnosis techniques such as flow cytometry is also increasing.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=2509&type=smp

Prominent Trend - Advancement In High-Throughput Flow Cytometry For Rapid Cell Parameter Analysis

High-throughput flow cytometry is an emerging trend in the flow cytometry market. This is due to high speed of cell parameter processing and capability to analyze several heterogeneous cell groups at once, using this technique. Traditional cytometry methods are very slow, especially when several cells need to be tested within a day. Using high-throughput flow cytometry methods such as fluorescence-activated cell-sorting (FACS), multiple cells can be allotted fluorescent markers which can be used to analyze their parameters in quick time. Examples of companies that offer high-throughput flow cytometry solutions include AstraZeneca and Novartis.

Flow Cytometry Market Players
Major companies operating in the flow cytometry market include Beckman Coulter Inc., Agilent Technologies Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Sysmex Corporation, Merck KGaA, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., General Electric Company, EMD Millipore Corporation, Affymetrix Inc., Biomérieux SA, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the flow cytometry market in 2023. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Flow Cytometry Market Report Structure
3. Flow Cytometry Market Trends And Strategies
4. Flow Cytometry Market - Macro Economic Scenario
5. Flow Cytometry Market Size And Growth
…..
27. Flow Cytometry Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.